Related Experiment Video
Updated: Jul 17, 2026
10:39
In Vitro Analysis of Myd88-mediated Cellular Immune Response to West Nile Virus Mutant Strain Infection
Published on: November 27, 2014
Immune responses to myxoma virus
1Pest Animal Control Cooperative Research Centre, CSIRO Sustainable Ecosystems, Canberra, ACT, Australia. Peter.Kerr@csiro.au
Viral Immunology
|June 26, 2002
Summary
Myxoma virus, a poxvirus, causes disease in European rabbits by suppressing their immune systems. Understanding its molecular interactions is key to studying rabbit resistance and the virus
Area of Science:
- Virology and Immunology
- Infectious Disease Dynamics
- Evolutionary Biology
Background:
- Myxoma virus (MYXV) causes severe myxomatosis in European rabbits (Oryctolagus cuniculus), a species it jumped to from South American rabbits.
- MYXV, a poxvirus, possesses genes encoding proteins that modulate host immune responses, including innate and acquired immunity.
- Viral proteins inhibit apoptosis and facilitate replication in host immune cells like lymphocytes and monocytes.
Purpose of the Study:
- To review detailed molecular studies of myxoma virus.
- To discuss the pathogenesis of myxomatosis in rabbits.
- To explore the evolution of genetic resistance in wild rabbits and the species barrier.
Main Methods:
- Review of existing literature on myxoma virus molecular biology.
- Analysis of viral proteins involved in immune evasion.
- Discussion of host-pathogen interactions and immune responses.
Main Results:
- Detailed molecular characterization of MYXV proteins reveals novel immune evasion strategies.
- Understanding viral replication mechanisms in host immune cells provides insights into pathogenesis.
- Limited knowledge exists on the dynamics of host-immune system interaction during infection and resistance evolution.
Conclusions:
- Molecular studies illuminate MYXV's interaction with the host immune system.
- Further research is needed on the integrated host-immune response dynamics and genetic resistance to myxomatosis.
- Investigating the species barrier and coevolution provides a model for large DNA virus-host interactions.
Related Concept Videos
01:40Cell-mediated Immune Responses
Overview
01:36Humoral Immune Responses
Overview
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...